NO20022149L - Ikke-viralt genleveringssystem - Google Patents

Ikke-viralt genleveringssystem

Info

Publication number
NO20022149L
NO20022149L NO20022149A NO20022149A NO20022149L NO 20022149 L NO20022149 L NO 20022149L NO 20022149 A NO20022149 A NO 20022149A NO 20022149 A NO20022149 A NO 20022149A NO 20022149 L NO20022149 L NO 20022149L
Authority
NO
Norway
Prior art keywords
delivery system
gene delivery
viral gene
viral
gene
Prior art date
Application number
NO20022149A
Other languages
English (en)
Other versions
NO317654B1 (no
NO20022149D0 (no
Inventor
Kristoffer Toemmeraas
Per Artursson
Bjoern Erik Christensen
Magnus Koeping-Hoeggaard
Kjell Morten Vaarum
Original Assignee
Pharmaconcepts Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaconcepts Ab filed Critical Pharmaconcepts Ab
Priority to NO20022149A priority Critical patent/NO317654B1/no
Publication of NO20022149D0 publication Critical patent/NO20022149D0/no
Priority to CNA038123487A priority patent/CN1655826A/zh
Priority to JP2004500923A priority patent/JP2005538943A/ja
Priority to EP03725898A priority patent/EP1549349A1/en
Priority to CA002491708A priority patent/CA2491708A1/en
Priority to AU2003228157A priority patent/AU2003228157A1/en
Priority to PCT/NO2003/000144 priority patent/WO2003092740A1/en
Priority to US10/513,311 priority patent/US20050164964A1/en
Publication of NO20022149L publication Critical patent/NO20022149L/no
Publication of NO317654B1 publication Critical patent/NO317654B1/no
Priority to US11/848,399 priority patent/US20080085242A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20022149A 2002-05-03 2002-05-03 Formulering som inneholder en nukleinsyre og et kitosan, fremgangsmate for fremstilling av formuleringen, samt anvendelser derav. NO317654B1 (no)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NO20022149A NO317654B1 (no) 2002-05-03 2002-05-03 Formulering som inneholder en nukleinsyre og et kitosan, fremgangsmate for fremstilling av formuleringen, samt anvendelser derav.
US10/513,311 US20050164964A1 (en) 2002-05-03 2003-05-02 Non-viral gene delivery system
CA002491708A CA2491708A1 (en) 2002-05-03 2003-05-02 Non-viral gene delivery system
JP2004500923A JP2005538943A (ja) 2002-05-03 2003-05-02 非ウイルス性遺伝子送達システム
EP03725898A EP1549349A1 (en) 2002-05-03 2003-05-02 Non-viral gene delivery system
CNA038123487A CN1655826A (zh) 2002-05-03 2003-05-02 非病毒类基因送递系统
AU2003228157A AU2003228157A1 (en) 2002-05-03 2003-05-02 Non-viral gene delivery system
PCT/NO2003/000144 WO2003092740A1 (en) 2002-05-03 2003-05-02 Non-viral gene delivery system
US11/848,399 US20080085242A1 (en) 2002-05-03 2007-08-31 Non-viral gene delivery system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20022149A NO317654B1 (no) 2002-05-03 2002-05-03 Formulering som inneholder en nukleinsyre og et kitosan, fremgangsmate for fremstilling av formuleringen, samt anvendelser derav.

Publications (3)

Publication Number Publication Date
NO20022149D0 NO20022149D0 (no) 2002-05-03
NO20022149L true NO20022149L (no) 2003-11-04
NO317654B1 NO317654B1 (no) 2004-11-29

Family

ID=19913596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022149A NO317654B1 (no) 2002-05-03 2002-05-03 Formulering som inneholder en nukleinsyre og et kitosan, fremgangsmate for fremstilling av formuleringen, samt anvendelser derav.

Country Status (8)

Country Link
US (2) US20050164964A1 (no)
EP (1) EP1549349A1 (no)
JP (1) JP2005538943A (no)
CN (1) CN1655826A (no)
AU (1) AU2003228157A1 (no)
CA (1) CA2491708A1 (no)
NO (1) NO317654B1 (no)
WO (1) WO2003092740A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040016013A1 (en) * 2002-07-18 2004-01-22 Gonzalo Hortelano Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent
WO2006030730A1 (ja) * 2004-09-15 2006-03-23 Otsuka Pharmaceutical Co., Ltd. 経粘膜用組成物、及び経粘膜吸収の向上方法
KR100718077B1 (ko) * 2005-09-12 2007-05-14 재단법인서울대학교산학협력재단 만노스화 키토산 유도체 및 이를 이용한 유전자 전달체
AU2007285472B2 (en) * 2006-03-30 2013-10-24 Engene, Inc. Non-viral compositions and methods for transfecting gut cells in vivo
CN100577688C (zh) * 2006-04-19 2010-01-06 中国科学院化学研究所 超支化壳聚糖或超支化乙二醇壳聚糖及其制备方法
WO2008031899A2 (en) * 2006-09-15 2008-03-20 Fmc Biopolymer As Oligonucleotide non-viral delivery systems
KR100825519B1 (ko) * 2007-01-05 2008-04-25 주식회사 바이오폴리메드 키토산 기재 고분자 접합체 및 그 제조방법
EP2638917A1 (en) 2007-06-29 2013-09-18 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Method of fixing and expressing physiologically active substance
ES2660846T3 (es) * 2007-09-28 2018-03-26 Engene, Inc. Composiciones poliplex de quitosano-ácido nucleico de alta concentración
WO2010111787A1 (en) * 2009-03-31 2010-10-07 Engene, Inc. Highly acidic chitosan-nucleic acid polyplex compositions
US20130337067A1 (en) 2012-06-15 2013-12-19 The Royal Institution For The Advancement Of Learning/Mcgill University Non-viral nanoparticle-based delivery system
CA2889841C (en) * 2012-10-29 2021-12-28 The Board Of Trustees Of The University Of Arkansas Novel mucosal adjuvants and delivery systems
CN106978444B (zh) * 2016-01-15 2021-12-17 江苏命码生物科技有限公司 一种向细胞中导入核酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316007B1 (en) * 1995-04-04 2001-11-13 Wound Healing Of Oklahoma Combined physical and immunotherapy for cancer
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
AU3739697A (en) * 1996-07-09 1998-02-02 Johns Hopkins University, The Gene delivery system
GB9713980D0 (en) * 1997-07-03 1997-09-10 Danbiosyst Uk New conjugates

Also Published As

Publication number Publication date
CN1655826A (zh) 2005-08-17
US20050164964A1 (en) 2005-07-28
NO317654B1 (no) 2004-11-29
JP2005538943A (ja) 2005-12-22
US20080085242A1 (en) 2008-04-10
CA2491708A1 (en) 2003-11-13
EP1549349A1 (en) 2005-07-06
NO20022149D0 (no) 2002-05-03
AU2003228157A1 (en) 2003-11-17
WO2003092740A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
DK1545662T3 (da) Lægemiddelindgivelsessystem
NO20041315L (no) Medikamentavleveringssystem
DK1481652T3 (da) Linseafgivelsessystem
DE602004018237D1 (de) Doppelhülliges Stenteinbringungssystem
NL1022316A1 (nl) Verbindingssysteem.
ATE405630T1 (de) Wirkstoffabgabesysteme
EP1793865A4 (en) GENETIC OR DRUG DELIVERY SYSTEM
ATE350331T1 (de) Dosiersystem
EP1497655A4 (en) IMPROVED GENE EXPRESSION SYSTEM
PL376169A1 (en) Drug delivery system
GB0426641D0 (en) Protein delivery system
EP1667619A4 (en) PHARMACEUTICAL FEEDING SYSTEM
NO20022149D0 (no) Ikke-viralt genleveringssystem
IL174906A0 (en) Flexible delivery system
NO20043646L (no) Osmotisk leveringssystem
DK1357642T3 (da) Tilslutningssystem
NO20022148L (no) Ikke-viralt genleveringssystem
DE60323800D1 (de) Bogenausleger
NO20052073D0 (no) ACC-gen.
AU2003273035A1 (en) Gene vaccine
AU2003299804A1 (en) An efficient non-viral gene/drug delivery system
NO20043613L (no) Genetisk polymorfi i preprotachykiningenet
AU2003238616A1 (en) Gene delivery system
ATE312330T1 (de) Verteilsystem
DE60220721D1 (de) Eduktor-mischersystem

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees